The “weight loss” group also showed decreased levels of APOE, C5, CRP, LBP, NEGR1, and PRSS3, which have all been positively associated with obesity, inflammation, and metabolic disorders (Fig. 3B to G) (22, –, 26). The gene discussed is PRSS3; the disease is Other metabolic disease.